Pancreatic Endocrine Tumors

Gastroenterology Clinics of North America

Volumn 36, Issue 2, 2007, Pages 431-439

  Jani, Niraj ^a   Moser, A James ^b   Khalid, Asif ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DACARBAZINE; DOXORUBICIN; MICRORNA; STREPTOZOCIN;

ADVANCED CANCER; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER TISSUE; CHEMOEMBOLIZATION; CLINICAL FEATURE; DNA MICROARRAY; ENDOCRINE TUMOR; ENDOSCOPIC ECHOGRAPHY; HUMAN; INSULINOMA; LAPAROSCOPIC SURGERY; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; RNA ANALYSIS; ZOLLINGER ELLISON SYNDROME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROENDOCRINE TUMORS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 34249335371     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2007.03.002     Document Type: Review

References (68)

1. Kloppel G., Schroder S., and Heitz P.U. Histopathology and immunopathology of pancreatic endocrine tumors. In: Mignon M., and Jensen R.T. (Eds). Endocrine tumors of the pancreas: recent advances in research and management. Series: Frontiers in Gastrointestinal Research vol. 23 (1995), S Karger, Basil (Switzerland) 99
2. Pearse A. The APUD concept and hormone production. Clin Endocrinol Metab 9 (1980) 211-222
3. Kloppel G., and Heitz P.U. Pancreatic endocrine tumors. Pathol Res Pract 183 2 (1988) 155-168
4. Heitz P.U., Kasper M., Polak J.M., et al. Pancreatic endocrine tumors. Hum Pathol 13 (1982) 263-271
5. Norton J.A., Doppman J.L., Collen M.J., et al. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg 204 (1986) 468-479
6. Soga J., Yakuwa Y., and Osaka M. Insulinomas/hypoglycemic syndrome: a statistical evaluation of 1085 reported cases of a Japanese series. J Exp Clin Cancer Res 17 (1998) 379-388
7. Fajans S.S., and Vinik A.I. Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am 18 (1989) 45-74
8. Broughan T.A., Leslie J.D., Soto J.M., et al. Pancreatic islet cell tumors. Surgery 99 (1986) 671-678
9. Schussheim D.H., Skarulis M.C., Agarwal S.K., et al. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 12 4 (2001) 173-178
10. Eelkema E.A., Stephens D.H., Ward E.M., et al. CT features of nonfunctioning islet cell carcinoma. AJR Am J Roentgenol 143 (1984) 943-948
11. Madura J.A., Cummings O., Wiebke E.A., et al. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort. Am Surg 63 (1997) 574-577
12. Pogany A.C., Kerlan R.K., Karam J.H., et al. Cystic insulinoma. AJR Am J Roentgenol 142 (1984) 951-952
13. Boukhman M.P., Karam J.M., Shaver J.S., et al. Localization of insulinomas. Arch Surg 134 (1999) 818-823
14. Galiber A.K., Reading C.C., Charboneau J.W., et al. Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT and angiography. Radiology 166 (1988) 405-408
15. Hashimoto L.A., and Wash R.M. Preoperative localization of insulinomas is not necessary. J Am Coll Surg 189 (1999) 368-373
16. King A.D., Ko G.T., Yeung V.T., et al. Dual phase spiral CT in detection of small insulinomas of the pancreas. Br J Radiol 71 (1998) 20-23
17. Keogan M.T., McDermott V.G., Paulson E.K., et al. Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification. Radiology 205 (1997) 513-518
18. Legmann P., Vignaux O., Dousset B., et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 170 (1998) 1315-1322
19. Chung M.J., Choi B.I., Han J.K., et al. Functioning islet cell tumor of the pancreas: localization with dynamic spiral CT. Acta Radiol 38 (1997) 135-138
20. Schirmer W.J., Melvin W.S., and Rush R.M. Indium-111-pentetreotide scanning versus conventional imaging techniques for localization of gastrinoma. Surgery 118 (1995) 1105-1113
21. Pavone P., Mitchell D.G., Leonetti F., et al. Pancreatic B-cell tumors: MRI. J Comput Assist Tomogr 17 (1993) 403-407
22. Ichikawa T., Peterson M.S., Federle M.P., et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 216 (2000) 163-171
23. Semelka R.C., Cumming M.J., Shoenut J.P., et al. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 186 (1993) 799-802
24. Alexander H.R., Fraker D.L., Norton J.A., et al. Prospective study on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg 228 (1998) 228-238
25. Gibril F., Reynolds J.C., Doppman J.L., et al. Somatostatin-receptor scintography: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 125 (1996) 26-34
26. Modlin I.M., Cornelius E., and Lawton G.P. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors. Arch Surg 130 (1995) 367-373
27. Weinel R.J., Neuhaus C., Stapp J., et al. Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintography. Ann Surg 218 (1993) 640-645
28. Kisker O., Bartsch D., Weinel R.J., et al. The value of somatostatin-receptor scintography in newly diagnosed endocrine gastroenteropancreatic tumors. J Am Coll Surg 184 (1997) 487-492
29. Signore A., Procaccini E., and Chianelli M. SPECT imaging with 111 In-octreotide for the localization of pancreatic insulinoma. Q J Nucl Med 39 (1995) 111-112
30. Schillaci O., Massa R., and Scopinaro F. 111 In-Pentetreotide scintography in the detection of insulinomas: importance of SPECT imaging. J Nucl Med 41 (2000) 459-462
31. Imamura M., Takahashi K., Adachi H., et al. Usefulness of selective arterial secretin injection test for localization of gastrinoma in Zollinger-Ellison syndrome. Ann Surg 205 (1987) 230-239
32. Doppman J.L., Miller D.L., and Chang R. Insulinomas: localization with selective intraarterial injection of calcium. Radiology 178 (1991) 237-241
33. Baba Y., Miyazono N., Nakajo M., et al. Localization of insulinomas: comparison of conventional arterial stimulation with venous sampling (ASVS) and superselective ASVS. Acta Radiol 41 (2000) 172-177
34. Rosch T., Lightdale C.J., Botet J.F., et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 326 (1992) 1721-1726
35. Gines A., Vazquez-Sequeiros E., Teresa Soria M., et al. Usefulness of EUS-guided needle aspiration (EUS-FNA) in the diagnosis of functioning neuroendocrine tumors. Gastrointest Endosc 56 (2002) 291-296
36. Anderson M.A., Carpenter S., Thompson N.W., et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95 (2000) 2271-2277
37. Sugiyama M., Abe N., Izumisato Y., et al. Differential diagnosis of benign versus malignant nonfunctioning islet cell tumors of the pancreas: the roles of EUS and ERCP. Gastrointest Endosc 55 (2002) 115-119
38. Bansal R., Tierney W., Carpenter S., et al. Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 49 (1999) 19-25
39. Grant C.S., van Heerden J., Charboneau J.W., et al. Insulinoma: The value of intraoperative ultrasonography. Arch Surg 123 (1988) 843-848
40. Norton J.A., Cromack D.T., Shawker T.H., et al. Intraoperative ultrasonographic localization of islet cell tumors: a prospective comparison to palpation. Ann Surg 207 (1988) 160-168
41. Zeiger M.A., Shawker T.H., and Norton J.A. Use of intraoperative ultrasonography to localize islet cell tumors. World J Surg 17 (1993) 448-454
42. Frucht H., Norton J.A., London J.F., et al. Detection of duodenal gastrinomas by operative endoscopic transillumination. Gastroenterology 99 (1990) 1622-1627
43. Capella C., Heitz P.U., Hofler H., et al. Revised classification of neuroendocrine tumours of the lung, pancreas, and gut. Virchows Arch 425 (1995) 547-560
44. Heymann M.F., Joubert M., Nemeth J., et al. Prognostic and immunohistochemical validation of the Capella classification of pancreatic neuroendocrine tumours: an analysis of 82 sporadic cases. Histopathology 36 (2000) 421-432
45. Solcia E., Rindi G., Paolotti D., et al. Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract. Ann Oncol 10 (1999) 9-15
46. Heitz P.U., Komminoth P., Perren A., et al. Tumors of the endocrine pancreas. In: DeLellis R.A., Lloyd R.V., Heitz P.U., et al. (Eds). World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs (2004), IARC Press, Lyon (France) 175-208
47. La Rosa S., Sessa F., Capella C., et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumors. Virchows Arch 429 6 (1996) 323-333
48. Panzuto F., Nasoni S., Falconi M., et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12 4 (2005) 1083-1092
49. Deshpande V., Fernandez-del Castillo C., Muzikansky A., et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 28 (2004) 1145-1153
50. Hochwald S.N., Zee S., Conlon K.C., et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 20 (2002) 2633-2642
51. Speel E.J., Richter J., Moch H., et al. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol 155 (1999) 1787-1794
52. Speel E.J., Scheidweiler A.F., Zhao J., et al. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. Cancer Res 61 13 (2001) 5186-5192
53. Zhao J., Moch H., Scheidweiler A.F., et al. Genomic imbalances in the progression of endocrine pancreatic tumors. Genes Chromosomes Cancer 32 4 (2001) 364-372
54. Stumpf E., Aalto Y., Hoog A., et al. Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer 29 1 (2000) 83-87
55. Barghorn A., Komminoth P., Bachmann D., et al. Deletion at 3p25. J Pathol 194 (2001) 451-458
56. Barghorn A., Speel E.J., Farspour B., et al. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am J Pathol 158 (2001) 1903-1911
57. Nodit L., McGrath K.M., Zahid M., et al. Endoscopic ultrasound-guided fine needle aspirate microsatellite loss analysis and pancreatic endocrine tumor outcome. Clin Gastroenterol Hepatol 4 12 (2006) 1474-1478
58. Roldo C., Missiaglia E., Hagan J.P., et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24 29 (2006) 4677-4684
59. Carty S.E., Jensen R.T., and Norton J.A. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 112 (1992) 1024-1031
60. Que F.G., Nagorney D.M., Batts K.P., et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 169 (1995) 36-42
61. Spitz J.D., Lilly M.C., Tetik C., et al. Ultrasound-guided laparoscopic resection of pancreatic islet cell tumors. Surg Laparosc Endosc Percutan Tech 10 (2000) 168-173
62. Sa Cunha A., Beau C., Rault A., et al. Laparoscopic versus open approach for solitary insulinoma. Surg Endosc 21 1 (2007) 103-108
63. Toniato A., Meduri F., Foletto M., et al. Laparoscopic treatment of benign insulinomas localized in the body and tail of the pancreas: a single-center experience. World J Surg 30 10 (2006) 1916-1919
64. Moertel C.G., Lefkopoulo M., Lipsitz S., et al. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 326 (1992) 519-523
65. Musunuru S., Chen H., Rajpal S., et al. Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg 141 10 (2006) 1000-1004
66. Norton J.A., Alexander H.R., Fraker D.L., et al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 234 4 (2001) 495-505
67. Norton J.A., Fraker D.L., Alexander H.R., et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341 9 (1999) 635-644
68. Jurgensen C., Schuppan D., Neser F., et al. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 63 7 (2006) 1059-1062